Literature DB >> 11497426

The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo.

L P Ford1, J W Shay, W E Wright.   

Abstract

La is an important component of ribonucleoprotein complexes and telomerase is a ribonucleoprotein that compensates for the shortening of the ends of linear DNA by adding telomeric repeats onto the ends of chromosomes by using an integral RNA as the template. We have identified a direct and specific interaction between La and the RNA component of human telomerase. Antibodies specific to La precipitate the human telomerase ribonucleoprotein complex derived from tumor cells, telomerase immortalized normal cells, and in vitro transformed cells. Overexpression of La in both experimentally immortalized human cells and prostate cancer cells results in gradual telomere shortening. Our results demonstrate that La can associate with telomerase and its expression level can influence telomere homeostasis in vivo.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11497426      PMCID: PMC1370155          DOI: 10.1017/s1355838201010159

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  44 in total

1.  Secondary structure of vertebrate telomerase RNA.

Authors:  J L Chen; M A Blasco; C W Greider
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies.

Authors:  S X Deng; E Hanson; I Sanz
Journal:  Int Immunol       Date:  2000-04       Impact factor: 4.823

3.  Anti-telomere antibodies in systemic lupus erythematosus.

Authors:  M Reichlin
Journal:  Lupus       Date:  2000       Impact factor: 2.911

4.  Subsenescent telomere lengths in fibroblasts immortalized by limiting amounts of telomerase.

Authors:  M M Ouellette; M Liao; B S Herbert; M Johnson; S E Holt; H S Liss; J W Shay; W E Wright
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

5.  U snRNP assembly in yeast involves the La protein.

Authors:  D Xue; D A Rubinson; B K Pannone; C J Yoo; S L Wolin
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

6.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

7.  Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death.

Authors:  B Herbert; A E Pitts; S I Baker; S E Hamilton; W E Wright; J W Shay; D R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

8.  Heterogeneous nuclear ribonucleoprotein A1 and UP1 protect mammalian telomeric repeats and modulate telomere replication in vitro.

Authors:  F Dallaire; S Dupuis; S Fiset; B Chabot
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

9.  Identification of two RNA-binding proteins associated with human telomerase RNA.

Authors:  S Le; R Sternglanz; C W Greider
Journal:  Mol Biol Cell       Date:  2000-03       Impact factor: 4.138

10.  In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs.

Authors:  F Dragon; V Pogacić; W Filipowicz
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

View more
  15 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

Review 2.  The biogenesis and regulation of telomerase holoenzymes.

Authors:  Kathleen Collins
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

3.  The human La (SS-B) autoantigen interacts with DDX15/hPrp43, a putative DEAH-box RNA helicase.

Authors:  Michael A Fouraux; Marloes J M Kolkman; Annemarie Van der Heijden; Arjan S De Jong; Walther J Van Venrooij; Ger J M Pruijn
Journal:  RNA       Date:  2002-11       Impact factor: 4.942

Review 4.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

5.  Holoenzyme proteins required for the physiological assembly and activity of telomerase.

Authors:  Keren L Witkin; Kathleen Collins
Journal:  Genes Dev       Date:  2004-05-06       Impact factor: 11.361

6.  A peptide from autoantigen La blocks poliovirus and hepatitis C virus cap-independent translation and reveals a single tyrosine critical for La RNA binding and translation stimulation.

Authors:  Raquel E Izumi; Saumitra Das; Bhaswati Barat; Santanu Raychaudhuri; Asim Dasgupta
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

7.  Human La protein interaction with GCAC near the initiator AUG enhances hepatitis C Virus RNA replication by promoting linkage between 5' and 3' untranslated regions.

Authors:  Anuj Kumar; Upasana Ray; Saumitra Das
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

8.  Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo.

Authors:  Yie Liu; Bryan E Snow; Valerie A Kickhoefer; Natalie Erdmann; Wen Zhou; Andrew Wakeham; Marla Gomez; Leonard H Rome; Lea Harrington
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

9.  The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle.

Authors:  Michael J Poderycki; Leonard H Rome; Lea Harrington; Valerie A Kickhoefer
Journal:  Nucleic Acids Res       Date:  2005-02-08       Impact factor: 16.971

10.  Telomerase confers resistance to caspase-mediated apoptosis.

Authors:  Yira Bermudez; Diana Erasso; Nicole C Johnson; Michelle Y Alfonso; Nancy E Lowell; Patricia A Kruk
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.